Oseltamivir Cuts Risk of Flu-Related ICU Admission, Shortens Hospital Stays in Kids, Data Suggest

Oseltamivir cuts risk of flu-related ICU admission, shortens hospital stays in kids, data suggest

The real-world study linked the antiviral to a 31% lower risk of needing intensive care, regardless of time to treatment.

AAP releases influenza vaccine recommendations for all children 6 months and older

Researchers from the American Academy of Pediatrics Committee on Infectious Diseases updated recommendations for the use of influenza vaccines and antiviral medications in the prevention and treatment of influenza in children during the 2026–2027 influenza season.

Antiviral treatment lowers ICU risk for children with influenza

A new nationwide study finds antiviral treatment is linked to fewer intensive care unit (ICU) admissions and shorter hospital stays for children hospitalized with influenza.

Large study finds early flu antivirals reduce ICU admissions in

A nationwide analysis of children hospitalized with laboratory-confirmed influenza has found that treatment with the antiviral drug oseltamivir was associated with a substantially lower risk of intensive care admission and shorter hospital stays. Published in JAMA Pediatrics, the study represents one of the largest real-world evaluations of antiviral effectiveness in pediatric influenza and arrives as […]

Largest Real-World Study Finds Early Flu Antiviral Treatment Reduces ICU Admissions in Hospitalized Children

Largest Real-World Study Finds Early Flu Antiviral Treatment Reduces ICU Admissions in Hospitalized Children